Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage

BACKGROUND: Recently, there has been an increased use of recombinant activated factor VII (rFVIIa) to promote hemostasis in various hemorrhagic conditions. The objective of this study was to determine the outcome of patients treated with rFVIIa who had intractable bleeding associated with cardiac su...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Thromb J
Principais autores:	Aggarwal, Anita, Malkovska, Vera, Catlett, Joseph P, Alcorn, Kirsten
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2004
Assuntos:	Case Report
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC535534/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15530167/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1477-9560-2-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!